DuPont will pay $1 billion in damages to Monsanto for willfully infringing its patent protecting the Roundup Ready soy gene. The federal jury made its decision in less than an hour following a near month-long trial held in the US District Court in St. Louis. DuPont is preparing to appeal, stressing that the jury had been deprived of important facts and arguments that may have changed the outcome. DuPont will likely also appeal the $1 billion amount of damages specifically, as it never actually put its patent-infringing soybeans on the market.
DuPont has a suit pending against Monsanto that claims its competitor uses its patents in a way that violates antitrust laws.
Monsanto’s Roundup Ready gene is found in over 90 percent of US soybeans, and allows farmers to use herbicide without damaging their crop.
Full content: NY Times
Related content: Transgenic Seed: The High Technology Test of Antitrust?
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
ConocoPhillips Acquires Marathon Oil for $22.5 Billion in Major Energy Sector Consolidation
May 29, 2024 by
CPI
Judge Denies Amazon’s Bid to Dismiss FTC Lawsuit Over Prime Membership Practices
May 29, 2024 by
CPI
Germany and France Advocate for Major EU Competition Reform
May 29, 2024 by
CPI
Equifax Accused of Monopolizing Employment Verification Market in New Suit
May 29, 2024 by
CPI
Car Battery Makers to Challenge EU Cartel Charges in Brussels
May 29, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Merger Guidelines Retrospective
May 21, 2024 by
CPI
Mergers of Complements
May 21, 2024 by
CPI
Personality Traits, Private Equity, and Merger Analysis
May 21, 2024 by
CPI
The 2023 Merger Guidelines: Lessons in the Importance of Incipiency, Modern Economics, and Monopsony
May 21, 2024 by
CPI
The 2023 Merger Guidelines: Sharpening Merger Analysis
May 21, 2024 by
CPI